The American Journal of Medicine
Volume 122, Issue 1, Supplement , Pages S51-S59 , January 2009

Hypercholesterolemia Treatment Patterns and Low-Density Lipoprotein Cholesterol Monitoring in Patients with a Diagnosis of Atherosclerosis in Clinical Practice

  • Michael H. Davidson, MD

      Affiliations

    • Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Michael H. Davidson, MD, Radiant Research, 515 North State Street, Suite 2700, Chicago, Illinois 60610
    • ,
  • Sanjay K. Gandhi, PhD

      Affiliations

    • AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA
    • ,
  • Robert L. Ohsfeldt, PhD

      Affiliations

    • Department of Health Policy & Management, Texas A&M Health Science Center, College Station, Texas, USA
    • ,
  • Kathleen M. Fox, PhD

      Affiliations

    • Department of Epidemiology & Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA

References 

  1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504
  2. Robinson JG, Leon AS. The prevention of cardiovascular disease: emphasis on secondary prevention. Med Clin North Am. 1994;78:69–98
  3. Patrick DL, Erickson P. Health Status and Health Policy: Allocating Resources to Health Care. In: New York: Oxford University Press; 1993;p. 1–478
  4. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol. 1997;80:1429–1433
  5. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080–2086
  6. Kannel WB, Wolf PA. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham study. Curr Atheroscler Rep. 2006;8:317–323
  7. Castelli W. Lipoproteins and cardiovascular disease: biological basis and epidemiological studies. Value Health. 1998;1:105–109
  8. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  9. Pyorala K, Wood D. Prevention of coronary heart disease in clinical practice: European recommendations revised and reinforced. Eur Heart J. 1998;19:1413–1415
  10. DeBacker G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice (Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice). Eur Heart J. 2003;24:1601–1610
  11. Nissen SE, Nicholls SJ, Sipahi I, et al. ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556–1565
  12. Crouse JR, Raichlen JS, Riley WA, et al. METEOR Study Group Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA. 2007;297:1344–1353
  13. Nissen SE, Tuzcu EM, Brown BG, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291:1071–1080
  14. Pearson TA, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459–467
  15. Davidson MH, Maki KC, Pearson TA, et al. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP writing group recommendations. Am J Cardiol. 2005;96:556–563
  16. Grundy SM, Cleeman JI, Merz CN, et al. Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44:720–732
  17. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation. 2004;110:265–270
  18. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation. 2004;110:1061–1068
  19. Kiechl S, Willeit J Bruneck Study Group. The natural course of atherosclerosis (Part I: incidence and progression). Arterioscler Thromb Vasc Biol. 1999;19:1484–1490

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

 To access a slide kit for this article, please click here.

PII: S0002-9343(08)01021-8

doi: 10.1016/j.amjmed.2008.10.017

The American Journal of Medicine
Volume 122, Issue 1, Supplement , Pages S51-S59 , January 2009

Article Tools

* Image Usage & Resolution